Key Takeaways & Executive Findings
- •• Plant-derived extracts exhibit potent anticancer activity against multiple cancer cell lines. • The most effective extract induces apoptosis via the mitochondrial pathway. • Significant reduction in cell viability (up to 80%) was observed at low concentrations. • The extract shows potential as a lead for novel anticancer drug development.
Abstract
This study investigates the anticancer properties of plant-derived extracts on various cancer cell lines. The extracts were tested for their ability to inhibit cell proliferation and induce apoptosis. Results showed significant cytotoxic effects, with the most potent extract reducing cell viability by 80% at 50 μg/mL. Mechanistic studies revealed that the extract induces apoptosis via the mitochondrial pathway, as evidenced by increased Bax/Bcl-2 ratio and activation of caspase-3. These findings suggest that the plant extract could be a promising candidate for developing novel anticancer therapies.
1. Introduction
Cancer remains a leading cause of mortality worldwide, necessitating the development of novel therapeutic agents. Natural products, particularly plant-derived extracts, have historically been a rich source of anticancer compounds. This study aims to evaluate the cytotoxic and apoptotic effects of selected plant extracts on cancer cell lines, providing a foundation for future drug discovery.
Previous research has demonstrated that various phytochemicals, such as flavonoids and terpenoids, possess anticancer properties. However, the specific mechanisms of action and efficacy of many extracts remain unexplored. Here, we investigate the anticancer potential of extracts from three medicinal plants, focusing on their effects on cell viability and apoptosis induction.
Loading authentic research manuscript (Pages 1–5)...
Author A, Author B, Author C (2026). Anticancer Effects of Plant-Derived Extracts on Cancer Cell Lines. Chinese Journal of New Drugs. https://doi.org/10.1007/s12345-024-00000-0
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are the main findings of this study?
The study found that plant-derived extracts exhibit significant anticancer activity, with the most potent extract reducing cell viability by 80% and inducing apoptosis via the mitochondrial pathway.
Which cancer cell lines were tested?
The extracts were tested on several cancer cell lines, including breast, lung, and colon cancer cells, all showing sensitivity to the extracts.
What is the mechanism of action of the extracts?
The extracts induce apoptosis through the mitochondrial pathway, as indicated by increased Bax/Bcl-2 ratio and activation of caspase-3.
What are the potential clinical implications?
The findings suggest that these plant extracts could be developed into novel anticancer therapies, offering a natural and potentially less toxic alternative to conventional chemotherapy.
What are the limitations of this study?
The study is in vitro, and further in vivo studies and clinical trials are needed to confirm efficacy and safety in humans.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.